HIGHLIGHTS
- who: Nemany A. N. Hanafy et al. from the Institute of Nanoscience and Nanotechnology, Kafrelsheikh University, Kafrelsheikh, Egypt CNR NANOTEC-Istituto di Nanotecnologia, Via Monteroni, Lecce, Italy have published the paper: Simultaneous Administration of Bevacizumab with Bee-Pollen Extract-Loaded Hybrid Protein Hydrogel NPs Is a Promising Targeted Strategy against Cancer Cells, in the Journal: (JOURNAL)
- what: In the current study, the amount of FA-conjugated EPCIBP was calculated from a because of the amino contents of protamine and the good carboxylic activation of FA. This study focused on determining the anti-cancer properties of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.